SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-20-009522
Filing Date
2020-04-23
Accepted
2020-04-23 08:59:33
Documents
18
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A formdefa14a.htm DEFA14A 57700
2 formdafa14aslide18.jpg GRAPHIC 42926
3 formdafa14aslide19.jpg GRAPHIC 133582
4 formdafa14aslide20.jpg GRAPHIC 139676
5 formdafa14aslide21.jpg GRAPHIC 128240
6 formdafa14aslide22.jpg GRAPHIC 187951
7 formdafa14aslide23.jpg GRAPHIC 166166
8 formdafa14aslide24.jpg GRAPHIC 116242
9 formdafa14aslide25.jpg GRAPHIC 228739
10 formdafa14aslide26.jpg GRAPHIC 217276
11 formdafa14aslide27.jpg GRAPHIC 149259
12 formdafa14aslide28.jpg GRAPHIC 196414
13 formdafa14aslide29.jpg GRAPHIC 178070
14 formdafa14aslide30.jpg GRAPHIC 166589
15 formdafa14aslide31.jpg GRAPHIC 169609
16 formdafa14aslide32.jpg GRAPHIC 212040
17 formdafa14aslide33.jpg GRAPHIC 212005
18 formdafa14aslide34.jpg GRAPHIC 203458
  Complete submission text file 0001140361-20-009522.txt   3983339
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-01136 | Film No.: 20809375
SIC: 2834 Pharmaceutical Preparations